 | • レポートコード：GIR-2104Z11737 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ラルテグラビルのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ラルテグラビルの種類別市場規模（錠剤、経口粉末）、用途別市場規模（病院、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ラルテグラビルの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck & Co.、Hetero ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：錠剤、経口粉末 ・用途別分析2016年-2026年：病院、ドラッグストア、その他 ・ラルテグラビルの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ラルテグラビルのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ラルテグラビルのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ラルテグラビルの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ラルテグラビルの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Raltegravir market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Raltegravir size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Raltegravir market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Raltegravir market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablet
Oral Powder
Market segment by Application can be divided into
Hospital
Drug Store
Others
The key market players for global Raltegravir market are listed below:
Merck & Co.
Hetero
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Raltegravir Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Raltegravir Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Tablet
1.2.3 Oral Powder
1.3 Market Analysis by Application
1.3.1 Overview: Global Raltegravir Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Others
1.4 Global Raltegravir Market Size & Forecast
1.4.1 Global Raltegravir Sales in Value (2016-2026))
1.4.2 Global Raltegravir Sales in Volume (2016-2026)
1.4.3 Global Raltegravir Price by Type (2016-2026) & (USD/Unit)
1.5 Global Raltegravir Production Capacity Analysis
1.5.1 Global Raltegravir Total Production Capacity (2016-2026)
1.5.2 Global Raltegravir Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Raltegravir Market Drivers
1.6.2 Raltegravir Market Restraints
1.6.3 Raltegravir Trends Analysis
2 Manufacturers Profiles
2.1 Merck & Co.
2.1.1 Merck & Co. Details
2.1.2 Merck & Co. Major Business
2.1.3 Merck & Co. Raltegravir Product and Services
2.1.4 Merck & Co. Raltegravir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Hetero
2.2.1 Hetero Details
2.2.2 Hetero Major Business
2.2.3 Hetero Raltegravir Product and Services
2.2.4 Hetero Raltegravir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Raltegravir Sales by Manufacturer
3.1 Global Raltegravir Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Raltegravir Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Raltegravir
3.4 Market Concentration Rate
3.4.1 Top 3 Raltegravir Manufacturer Market Share
3.4.2 Top 6 Raltegravir Manufacturer Market Share
3.5 Global Raltegravir Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Raltegravir Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Raltegravir Market Size by Region
4.1.1 Global Raltegravir Sales in Volume by Region (2016-2026)
4.1.2 Global Raltegravir Revenue by Region (2016-2026)
4.2 North America Raltegravir Revenue (2016-2026)
4.3 Europe Raltegravir Revenue (2016-2026)
4.4 Asia-Pacific Raltegravir Revenue (2016-2026)
4.5 South America Raltegravir Revenue (2016-2026)
4.6 Middle East and Africa Raltegravir Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Raltegravir Sales in Volume by Type (2016-2026)
5.2 Global Raltegravir Revenue by Type (2016-2026)
5.3 Global Raltegravir Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Raltegravir Sales in Volume by Application (2016-2026)
6.2 Global Raltegravir Revenue by Application (2016-2026)
6.3 Global Raltegravir Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Raltegravir Sales by Type (2016-2026)
7.2 North America Raltegravir Sales by Application (2016-2026)
7.3 North America Raltegravir Market Size by Country
7.3.1 North America Raltegravir Sales in Volume by Country (2016-2026)
7.3.2 North America Raltegravir Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Raltegravir Sales by Type (2016-2026)
8.2 Europe Raltegravir Sales by Application (2016-2026)
8.3 Europe Raltegravir Market Size by Country
8.3.1 Europe Raltegravir Sales in Volume by Country (2016-2026)
8.3.2 Europe Raltegravir Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Raltegravir Sales by Type (2016-2026)
9.2 Asia-Pacific Raltegravir Sales by Application (2016-2026)
9.3 Asia-Pacific Raltegravir Market Size by Region
9.3.1 Asia-Pacific Raltegravir Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Raltegravir Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Raltegravir Sales by Type (2016-2026)
10.2 South America Raltegravir Sales by Application (2016-2026)
10.3 South America Raltegravir Market Size by Country
10.3.1 South America Raltegravir Sales in Volume by Country (2016-2026)
10.3.2 South America Raltegravir Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Raltegravir Sales by Type (2016-2026)
11.2 Middle East & Africa Raltegravir Sales by Application (2016-2026)
11.3 Middle East & Africa Raltegravir Market Size by Country
11.3.1 Middle East & Africa Raltegravir Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Raltegravir Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Raltegravir Typical Distributors
12.3 Raltegravir Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Raltegravir Revenue by Type, (USD Million), 2021-2026
Table 2. Global Raltegravir Revenue by Application, (USD Million), 2021-2026
Table 3. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co. Major Business
Table 5. Merck & Co. Raltegravir Product and Services
Table 6. Merck & Co. Raltegravir Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Hetero Basic Information, Manufacturing Base and Competitors
Table 8. Hetero Major Business
Table 9. Hetero Raltegravir Product and Services
Table 10. Hetero Raltegravir Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Global Raltegravir Sales by Manufacturer (2019-2021e) & (K Units)
Table 12. Global Raltegravir Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 13. Market Position of Manufacturers in Raltegravir, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 14. Global Raltegravir Production Capacity by Company, (K Units): 2020 VS 2021
Table 15. Head Office and Raltegravir Production Site of Key Manufacturer
Table 16. Global Raltegravir Sales by Region (2016-2021e) & (K Units)
Table 17. Global Raltegravir Sales by Region (2021-2026) & (K Units)
Table 18. Global Raltegravir Revenue by Region (2016-2021e) & (USD Million)
Table 19. Global Raltegravir Revenue by Region (2021-2026) & (USD Million)
Table 20. Global Raltegravir Sales by Type (2016-2021e) & (K Units)
Table 21. Global Raltegravir Sales by Type (2021-2026) & (K Units)
Table 22. Global Raltegravir Revenue by Type (2016-2021e) & (USD Million)
Table 23. Global Raltegravir Revenue by Type (2021-2026) & (USD Million)
Table 24. Global Raltegravir Price by Type (2016-2021e) & (USD/Unit)
Table 25. Global Raltegravir Price by Type (2021-2026) & (USD/Unit)
Table 26. Global Raltegravir Sales by Application (2016-2021e) & (K Units)
Table 27. Global Raltegravir Sales by Application (2021-2026) & (K Units)
Table 28. Global Raltegravir Revenue by Application (2016-2021e) & (USD Million)
Table 29. Global Raltegravir Revenue by Application (2021-2026) & (USD Million)
Table 30. Global Raltegravir Price by Application (2016-2021e) & (USD/Unit)
Table 31. Global Raltegravir Price by Application (2021-2026) & (USD/Unit)
Table 32. North America Raltegravir Sales by Country (2016-2021e) & (K Units)
Table 33. North America Raltegravir Sales by Country (2021-2026) & (K Units)
Table 34. North America Raltegravir Revenue by Country (2016-2021e) & (USD Million)
Table 35. North America Raltegravir Revenue by Country (2021-2026) & (USD Million)
Table 36. North America Raltegravir Sales by Type (2016-2021e) & (K Units)
Table 37. North America Raltegravir Sales by Type (2021-2026) & (K Units)
Table 38. North America Raltegravir Sales by Application (2016-2021e) & (K Units)
Table 39. North America Raltegravir Sales by Application (2021-2026) & (K Units)
Table 40. Europe Raltegravir Sales by Country (2016-2021e) & (K Units)
Table 41. Europe Raltegravir Sales by Country (2021-2026) & (K Units)
Table 42. Europe Raltegravir Revenue by Country (2016-2021e) & (USD Million)
Table 43. Europe Raltegravir Revenue by Country (2021-2026) & (USD Million)
Table 44. Europe Raltegravir Sales by Type (2016-2021e) & (K Units)
Table 45. Europe Raltegravir Sales by Type (2021-2026) & (K Units)
Table 46. Europe Raltegravir Sales by Application (2016-2021e) & (K Units)
Table 47. Europe Raltegravir Sales by Application (2021-2026) & (K Units)
Table 48. Asia-Pacific Raltegravir Sales by Region (2016-2021e) & (K Units)
Table 49. Asia-Pacific Raltegravir Sales by Region (2021-2026) & (K Units)
Table 50. Asia-Pacific Raltegravir Revenue by Region (2016-2021e) & (USD Million)
Table 51. Asia-Pacific Raltegravir Revenue by Region (2021-2026) & (USD Million)
Table 52. Asia-Pacific Raltegravir Sales by Type (2016-2021e) & (K Units)
Table 53. Asia-Pacific Raltegravir Sales by Type (2021-2026) & (K Units)
Table 54. Asia-Pacific Raltegravir Sales by Application (2016-2021e) & (K Units)
Table 55. Asia-Pacific Raltegravir Sales by Application (2021-2026) & (K Units)
Table 56. South America Raltegravir Sales by Country (2016-2021e) & (K Units)
Table 57. South America Raltegravir Sales by Country (2021-2026) & (K Units)
Table 58. South America Raltegravir Revenue by Country (2016-2021e) & (USD Million)
Table 59. South America Raltegravir Revenue by Country (2021-2026) & (USD Million)
Table 60. South America Raltegravir Sales by Type (2016-2021e) & (K Units)
Table 61. South America Raltegravir Sales by Type (2021-2026) & (K Units)
Table 62. South America Raltegravir Sales by Application (2016-2021e) & (K Units)
Table 63. South America Raltegravir Sales by Application (2021-2026) & (K Units)
Table 64. Middle East & Africa Raltegravir Sales by Country (2016-2021e) & (K Units)
Table 65. Middle East & Africa Raltegravir Sales by Country (2021-2026) & (K Units)
Table 66. Middle East & Africa Raltegravir Revenue by Country (2016-2021e) & (USD Million)
Table 67. Middle East & Africa Raltegravir Revenue by Country (2021-2026) & (USD Million)
Table 68. Middle East & Africa Raltegravir Sales by Type (2016-2021e) & (K Units)
Table 69. Middle East & Africa Raltegravir Sales by Type (2021-2026) & (K Units)
Table 70. Middle East & Africa Raltegravir Sales by Application (2016-2021e) & (K Units)
Table 71. Middle East & Africa Raltegravir Sales by Application (2021-2026) & (K Units)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Raltegravir Typical Distributors
Table 75. Raltegravir Typical Customers
List of Figures
Figure 1. Raltegravir Picture
Figure 2. Global Raltegravir Sales Market Share by Type in 2020
Figure 3. Tablet
Figure 4. Oral Powder
Figure 5. Global Raltegravir Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Drug Store
Figure 8. Others
Figure 9. Global Raltegravir Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Raltegravir Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Raltegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Raltegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Raltegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Raltegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Raltegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Raltegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Raltegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Raltegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Raltegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Raltegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Raltegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Raltegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Raltegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Raltegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Raltegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Raltegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Raltegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Raltegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Raltegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Raltegravir Sales (2016-2026) & (K Units)
Figure 31. Global Raltegravir Production Capacity (2016-2026) & (K Units)
Figure 32. Global Raltegravir Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Raltegravir Market Drivers
Figure 34. Raltegravir Market Restraints
Figure 35. Raltegravir Market Trends
Figure 36. Global Raltegravir Sales Market Share by Manufacturer in 2020
Figure 37. Global Raltegravir Revenue Market Share by Manufacturer in 2020
Figure 38. Raltegravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Raltegravir Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Raltegravir Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Raltegravir Sales Market Share by Region (2016-2026)
Figure 42. Global Raltegravir Revenue Market Share by Region (2016-2026)
Figure 43. North America Raltegravir Revenue (2016-2026) & (USD Million)
Figure 44. Europe Raltegravir Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Raltegravir Revenue (2016-2026) & (USD Million)
Figure 46. South America Raltegravir Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Raltegravir Revenue (2016-2026) & (USD Million)
Figure 48. Global Raltegravir Sales Market Share by Type (2016-2026)
Figure 49. Global Raltegravir Revenue Market Share by Type (2016-2026)
Figure 50. Global Raltegravir Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Raltegravir Sales Market Share by Application (2016-2026)
Figure 52. Global Raltegravir Revenue Market Share by Application (2016-2026)
Figure 53. Global Raltegravir Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Raltegravir Sales Market Share by Country (2016-2026)
Figure 55. North America Raltegravir Revenue Market Share by Country (2016-2026)
Figure 56. North America Raltegravir Sales Market Share by Type (2016-2026)
Figure 57. North America Raltegravir Sales Market Share by Application (2016-2026)
Figure 58. Europe Raltegravir Sales Market Share by Country (2016-2026)
Figure 59. Europe Raltegravir Revenue Market Share by Country (2016-2026)
Figure 60. Europe Raltegravir Sales Market Share by Type (2016-2026)
Figure 61. Europe Raltegravir Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Raltegravir Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Raltegravir Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Raltegravir Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Raltegravir Sales Market Share by Application (2016-2026)
Figure 66. South America Raltegravir Sales Market Share by Country (2016-2026)
Figure 67. South America Raltegravir Revenue Market Share by Country (2016-2026)
Figure 68. South America Raltegravir Sales Market Share by Type (2016-2026)
Figure 69. South America Raltegravir Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Raltegravir Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Raltegravir Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Raltegravir Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Raltegravir Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の薬物検査用口腔液市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Test Oral Fluid Market The global Drug Test Oral Fluid market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…- 世界の抗口腔粘膜炎薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti–Oral Mucositis Drug Market The global Anti–Oral Mucositis Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の抗口腔粘膜炎薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti–Oral Mucositis Drug Market The global Anti–Oral Mucositis Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界のバラシクロビル経口剤市場 2021：企業別、地域別、種類・用途別 The Valacyclovir Oral market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …
- 世界のミルタザピン薬市場 2021：企業別、地域別、種類・用途別 The Mirtazapine Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…